Affimed N.V. (NASDAQ:NASDAQ:NASDAQ:NASDAQ:AFMD) has announced that Shawn M. Leland, PharmD, RPh has been appointed as Chief Executive Officer (CEO). Dr. Andreas Harstrick, acting CEO since January 2024 will continue in his position as Chief Medical Officer (CMO). Most recently, Shawn was the Interim CEO and Board Director of ForeBio. Source: Press Release

More on Affimed

Affimed N.V. (AFMD) Q1 2024 Earnings Call Transcript Affimed N.V. 2024 Q1 - Results - Earnings Call Presentation Affimed: AFM24's Update Was Good, Acimtamig's Should Be Better Affimed says 86% of patients responded to lymphoma therapy in mid-stage trial Seeking Alpha's Quant Rating on Affimed